Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints

American Journal of Geriatric Psychiatry

Volumn 24, Issue 9, 2016, Pages 729-737

  Merrill, David A ^a   Siddarth, Prabha ^a   Raji, Cyrus A ^b   Emerson, Natacha D ^a   Rueda, Florangel ^a   Ercoli, Linda M ^a   Miller, Karen J ^a   Lavretsky, Helen ^a   Harris, Laurel M ^a   Burggren, Alison C ^a   Bookheimer, Susan Y ^a   Barrio, Jorge R ^b   Small, Gary W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; exercise; FDDNP; PET

Indexed keywords

2 [1 [6[ (2 [F18] FLUOROETHYL)(METHYL)AMINO] 2 NAPHTHYL]ETHYLIDENE]MALONONITRILE; AMYLOID; MALONONITRILE; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; BODY MASS; CLINICAL EXAMINATION; COGNITION; FEMALE; FRONTAL CORTEX; HUMAN; LIFESTYLE; MALE; MEDIAL TEMPORAL LOBE; MEDITERRANEAN DIET; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; PARIETAL CORTEX; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; RISK FACTOR; SELF REPORT; AGING; BRAIN; COGNITIVE DEFECT; DIAGNOSTIC IMAGING; EXERCISE; METABOLISM; MIDDLE AGED; NEUROFIBRILLARY TANGLE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PROTECTION; PSYCHOLOGY; SELF EVALUATION;

AGED; AGING; BRAIN; COGNITIVE DYSFUNCTION; DIET, MEDITERRANEAN; EXERCISE; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID; POSITRON-EMISSION TOMOGRAPHY; PROTECTIVE FACTORS; SELF-ASSESSMENT;

EID: 84990888828     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2016.05.007     Document Type: Article

References (40)

1. 1 Thies, W., Bleiler, L., 2014 Alzheimer's disease facts and figures. Alzheimers Dement 10 (2014), e47–e92.
2. 2 Barnes, D.E., Yaffe, K., The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10 (2011), 819–828.
3. 3 Merrill, D.A., Small, G.W., Prevention in psychiatry: effects of healthy lifestyle on cognition. Psychiatr Clin North Am 34 (2011), 249–261.
4. 4 Williams, J.W., Plassman, B.L., Burke, J., et al. Preventing Alzheimer's Disease and Cognitive Decline. Evidence Report/Technology Assessment No. 193. (Prepared by the Duke Evidence-based Practice Center under Contract No. HHSA 290-2007-10066-I.). AHRQ Publication No. 10-E005, 2010, Agency for Healthcare Research and Quality, Rockville, MD.
5. 5 Gage, F.H., Neurogenesis in the adult brain. J Neurosci 22 (2002), 612–613.
6. 6 Nagahara, A.H., Merrill, D.A., Coppola, G., et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15 (2009), 331–337.
7. 7 Kramer, A.F., Hahn, S., Cohen, N.J., et al. Ageing, fitness and neurocognitive function. Nature 400 (1999), 418–419.
8. 8 Erickson, K.I., Prakash, R.S., Voss, M.W., et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 19 (2009), 1030–1039.
9. 9 Erickson, K.I., Voss, M.W., Prakash, R.S., et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 108 (2011), 3017–3022.
10. 10 Scarmeas, N., Luchsinger, J.A., Schupf, N., et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 302 (2009), 627–637.
11. 11 Tangney, C.C., Kwasny, M.J., Li, H., et al. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am J Clin Nutr 93 (2011), 601–607.
12. 12 Panza, F., D'Introno, A., Colacicco, A.M., et al. Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51 (2006), 275–292.
13. 13 Elias, M.F., Elias, P.K., Sullivan, L.M., et al. Obesity, diabetes and cognitive deficit: the Framingham Heart Study. Neurobiol Aging 26:suppl 1 (2005), 11–16.
14. 14 Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66 (2009), 336–342.
15. 15 Wolf, P.A., Beiser, A., Elias, M.F., et al. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res 4 (2007), 111–116.
16. 16 Xu, W.L., Atti, A.R., Gatz, M., et al. Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology 76 (2011), 1568–1574.
17. 17 Taylor, R.W., Keil, D., Gold, E.J., et al. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 67 (1998), 44–49.
18. 18 U.S. Department of Agriculture, U.S. Department of Health and Human Services, Dietary Guidelines for Americans. 7th ed., 2010, U.S. Government Printing Office, Washington, DC.
19. 19 Ho, A.J., Raji, C.A., Becker, J.T., et al. Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging 31 (2010), 1326–1339.
20. 20 Raji, C.A., Ho, A.J., Parikshak, N.N., et al. Brain structure and obesity. Hum Brain Mapp 31 (2010), 353–364.
21. 21 Zimmerman, B., Sutton, B.P., Low, K.A., et al. Cardiorespiratory fitness mediates the effects of aging on cerebral blood flow. Front Aging Neurosci, 6, 2014, 59.
22. 22 Mrak, R.E., Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clin Neuropathol 28 (2009), 40–45.
23. 23 Toledo, J.B., Toledo, E., Weiner, M.W., et al. Cardiovascular risk factors, cortisol, and amyloid-beta deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement 8 (2012), 483–489.
24. 24 Vidoni, E.D., Townley, R.A., Honea, R.A., et al. Alzheimer disease biomarkers are associated with body mass index. Neurology 77 (2011), 1913–1920.
25. 25 Chen, S.T., Siddarth, P., Saito, N.Y., et al. Psychological well-being and regional brain amyloid and tau in mild cognitive impairment. Am J Geriatr Psychiatry 22 (2014), 362–369.
26. 26 Merrill, D.A., Siddarth, P., Kepe, V., et al. Vascular risk and FDDNP-PET influence cognitive performance. J Alzheimers Dis 35 (2013), 147–157.
27. 27 Merrill, D.A., Siddarth, P., Saito, N.Y., et al. Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia. Int Psychogeriatr 24 (2012), 1076–1084.
28. 28 Small, G.W., Siddarth, P., Kepe, V., et al. Prediction of cognitive decline by positron emission tomography of brain amyloid and tau. Arch Neurol 69 (2012), 215–222.
29. 29 Small, G.W., Kepe, V., Ercoli, L.M., et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355 (2006), 2652–2663.
30. 30 Smith, G.E., Petersen, R.C., Parisi, J.E., et al. Definition, course and outcome of mild cognitive impairment. Aging Neuropsychol Cogn 3 (1996), 141–147.
31. 31 de Jager, C.A., Budge, M.M., Stability and predictability of the classification of mild cognitive impairment as assessed by episodic memory test performance over time. Neurocase 11 (2005), 72–79.
32. 32 Hurtig-Wennlof, A., Hagstromer, M., Olsson, L.A., The International Physical Activity Questionnaire modified for the elderly: aspects of validity and feasibility. Public Health Nutr 13 (2010), 1847–1854.
33. 33 Craig, C.L., Marshall, A.L., Sjostrom, M., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35 (2003), 1381–1395.
34. 34 Loftfield, E., Yi, S., Immerwahr, S., et al. Construct validity of a single-item, self-rated question of diet quality. J Nutr Educ Behav 47 (2014), 181–187.
35. 35 Liu, J., Kepe, V., Zabjek, A., et al. High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]–2-naphthyl}ethylidene)malononi trile ([18F]FDDNP) ready for animal or human administration. Mol Imaging Biol 9 (2007), 6–16.
36. 36 Logan, J., Fowler, J.S., Volkow, N.D., et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16 (1996), 834–840.
37. 37 Cournot, M., Marquie, J.C., Ansiau, D., et al. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology 67 (2006), 1208–1214.
38. 38 Thomas, E.L., Frost, G., Taylor-Robinson, S.D., et al. Excess body fat in obese and normal-weight subjects. Nutr Res Rev 25 (2012), 150–161.
39. 39 Willett, K., Jiang, R., Lenart, E., et al. Comparison of bioelectrical impedance and BMI in predicting obesity-related medical conditions. Obesity (Silver Spring) 14 (2006), 480–490.
40. 40 Small, G.W., Siddarth, P., Ercoli, L.M., et al. Healthy behavior and memory self-reports in young, middle-aged, and older adults. Int Psychogeriatr 25 (2013), 981–989.